• Carbapenemase Gene Transmission in Guangdong CREC

  2026-09-08

  Chen et al. characterize carbapenemase-encoding genes in carbapenem-resistant Enterobacter cloacae collected from eight teaching hospitals in Guangdong during 2022–2024. By combining gene localization, susceptibility testing, conjugation, mobile-element analysis, and ERIC-PCR, the study links plasmid carriage with multidrug resistance and substantial horizontal-transfer potential.

• Methoxy-X04 for Amyloid Plaque Imaging Workflows

  2026-09-08

  Methoxy-X04 combines blood-brain barrier permeability with high-affinity amyloid labeling, supporting both in vivo plaque mapping and controlled tissue assays. This workflow-focused guide shows how to use the fluorescent amyloid beta probe to evaluate plaque clearance, microglial interventions, and cerebrovascular amyloid while avoiding common interpretation and handling errors.

• Decitabine Priming Expands CD8+ Progenitor Tex

  2026-09-07

  Li et al. show that low-dose decitabine can improve anti–PD-1 efficacy by expanding and functionally sustaining CD8+ progenitor exhausted T cells rather than simply intensifying checkpoint blockade. Their tumor-model and molecular data identify JunD-dependent AP-1 activity as a mechanistic link between epigenetic priming, progenitor-cell proliferation, and tumor control.

• Biotin-XX Tyramide Reagent for Surface Labeling

  2026-09-07

  Biotin-XX Tyramide Reagent combines HRP-driven tyramide signal amplification with a membrane-impermeant linker for selective cell surface protein labeling. This guide translates activity-sensitive proximity-labeling concepts into practical IHC, ISH, fluorescence, and surface-profiling workflows.

• NHS-Biotin for Assays of Multimeric Proteins

  2026-09-05

  NHS-Biotin enables stable amine-reactive labeling, but its greatest analytical value emerges when labeling is treated as a variable in multimeric protein assays. This guide connects N-hydroxysuccinimido biotin chemistry with peptidisc-assisted nanobody engineering and practical assay design.

• MMP7 Drives Liver Fibrosis in Biliary Atresia

  2026-09-04

  A 2026 study identifies MMP7 as a mechanistic driver of biliary atresia-associated liver fibrosis rather than only a diagnostic biomarker. By integrating patient samples, transcriptomic analysis, biliary epithelial cell experiments, and a chronic mouse model, the authors link MMP7 to E-cadherin cleavage, β-catenin nuclear translocation, epithelial–mesenchymal transition, and fibrotic progression.

• Optimizing CS/β-GP/HEC Hydrogels for 3D Culture

  2026-09-04

  Zhao and colleagues used a structured 2 × 2 × 2 factorial design to optimize a chitosan/β-glycerophosphate/hydroxyethyl cellulose hydrogel for injectable, thermoresponsive 3D cell culture. The selected G1 and G3 formulations combined room-temperature injectability with physiological-temperature gelation and supported viable, spatially organized growth of Huh7 cells and bone marrow-derived mesenchymal stem cells.

• UHRF1, Super-Enhancers, and Osteogenesis in SOP

  2026-09-03

  The reference study identifies a mechanistic connection between UHRF1-dependent DNA 5-methylcytosine regulation, super-enhancer redistribution, and TGM2-controlled autophagic flux in senile osteoporosis. Its multi-omics and functional validation strategy links epigenetic remodeling to impaired mesenchymal stem cell osteogenesis and suggests the UHRF1–TGM2 axis as a testable target for age-related bone loss.

• Phosphatase Inhibitor Cocktail 2: Assay Control

  2026-09-03

  Learn how Phosphatase Inhibitor Cocktail 2 supports protein phosphorylation preservation and improves assay interpretation through controlled sample handling, temperature, and orthogonal validation.

• Araucarene Diterpenes and β-Cell Regeneration

  2026-09-02

  This study identifies 16 araucarene diterpenes from Agathis dammara, including 11 previously unreported compounds, and links selected structures to hypoglycemic activity in zebrafish. Its central mechanistic contribution is the evidence that araucarone and dammaric acid C may lower glucose by promoting pancreatic β-cell regeneration and enhancing glucose uptake.

• Fucoidan: Decoding the Gut–Liver Axis

  2026-09-02

  Fucoidan is a sulfated α-L-fucan with established anticancer and immune-modulating activity. This article explains how new gut–liver axis evidence reframes Fucoidan research toward chemotherapy-associated liver injury, barrier function, NETs, and multidimensional assay design.

• LY2886721: A Strategic BACE1 Research Playbook

  2026-09-01

  LY2886721 offers translational researchers a potent oral BACE inhibitor for connecting BACE1 enzyme inhibition with amyloid beta reduction, biomarker movement, and synaptic-function boundaries. This article frames the compound as a controlled research tool for Alzheimer’s disease treatment research rather than as a standalone promise of clinical efficacy.

• Protease and Phosphatase Inhibitor Cocktail: EDTA-Free

  2026-09-01

  Protease and Phosphatase Inhibitor Cocktail K4006 is a 100X, EDTA-free aqueous reagent for limiting proteolysis and dephosphorylation during biological sample extraction or lysis. It is suitable when preservation of protein integrity and phosphorylation is needed without metal chelation, but it should not replace EDTA in workflows that specifically require chelation.

• PFHxS Hepatotoxicity Through PPAR Signaling

  2026-08-31

  The reference study shows that environmentally relevant PFHxS exposure can damage liver development and function in larval zebrafish through a PPAR-centered mechanism. Its combination of transcriptomics, pathology, biochemical measurements, pharmacological antagonism, and morpholino knockdown provides a useful framework for mechanistic aquatic toxicology and cellular metabolism research.

• Chrysin, NOX2, and Ferroptosis in Dry Eye

  2026-08-31

  A 2026 study links NOX2-driven oxidative stress and STING/NLRP3 inflammation to ferroptotic corneal epithelial injury in dry eye. Using transcriptomics, cell models, and benzalkonium chloride-induced dry eye mice, the authors show that chrysin improves ocular surface outcomes while suppressing lipid peroxidation, iron overload, and inflammatory signaling.

8419 records 1/562 page Next 12345 下5页 Last page